Sphingomyelin, Plasminogen, and Docosahexaenoic in Sera of Autism Spectrum Disorder Children

Ali Fadheel Hamoud, Narjis Hadi Al-Saadi

Abstract


Background: Autism spectrum disorder (ASD), more commonly referred to as autism, is a neurodevelopmental disorder that is pervasive, highly heritable, and extremely variable. It is characterized by underlying cognitive features that frequently co-occur with other conditions. Since ASD is a multifactor disease, genetics, and environmental factors can play crucial roles in its progression. However, very few biological parameters can be used as a prediction for ASD which can help in diagnosis and starting the treatment early. Given the rapidly increasing prevalence of ASD, there is an urgent need to identify related diagnostic biomarkers.  This study aims to investigate the association between some blood parameters that can be used to predict ASD and classify the severity, which were the main aims of the current inquiry.

Method: A case-control study was conducted on children with ASD, 37 Kids with ASD participated in the current investigation and 46 kids as the control group, their ages were between 3-12 years. Children with ASD were divided into two subgroups depending on the severity of ASD using the Gilliam scale. Competitive and sandwich ELISA were used to measure the biochemical markers of this study.

Result: After blood samples were collected three parameters were measured (sphingomyelin, plasminogen, and docosahexaenoic acid). In medium ASD cases, the results display that there is a significant increase in all parameters (sphingomyelin, plasminogen, and docosahexaenoic acid) respectively [(OR:4.691, CI:1.289~17.068, p=0.014), (OR:7.5, CI:1.844~30.509, p=0.001), (OR:5.156, CI:1.412~18.831, p=0.001)]. On other hand, in under medium cases of ASD, there is a significant decrease in Sphingomyelin levels (OR:0.97, CI:0.356~0.836, p=0.001), plasminogen (OR: 0.5, CI: 0.169~0.560, p=0.05), and docosahexaenoic (OR: 0.22, CI: 0.63~1.771, p=0.003) when compared with the control group.

Conclusion: In sum, our results showed that these noninvasive parameters can be used as biomarkers for ASD diagnosis and disease propagation. More research needs to be done to cover other pathophysiology parameters with genetics analysis for ASD that can be used as prediction biomarkers.

Keywords: Autism spectrum disorder; Sphingomyelin; Plasminogen; Docosahexaenoic acid 


Full Text:

PDF

References


Gontard A Von, Hussong J, Yang SS, Chase J, Franco I, Wright A. Aims Mathematics, (2021);41(1):1–9.

Rosen NE, Lord C, Volkmar FR. The Diagnosis of Autism: From Kanner to DSM-III to DSM-5 and Beyond. Journal of autism and developmental disorders,(2021);51(12):4253–70.

Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Jones EJH, et al. Autism spectrum disorder Access options Access Nature and 54 other Nature Portfolio journals, (2020);6(1):1–46.

Zhu J, Guo M, Yang T, Lai X, Tang T, Chen J, et al. Nutritional Status and Symptoms in Preschool Children With Autism Spectrum Disorder: A Two-Center Comparative Study in Chongqing and Hainan Province, China. Frontiers in Pediatrics, (2020);8(469):1–28.

Patel, Goyena R. Prevalence of Depression in Children with Dyslexia, Attention Deficit Hyperactivity Disorder, and High Functioning Autism Spectrum Disorder. Journal of Chemical Information and Modeling, (2019);15(2):9–25.

Okoye C, Obialo-Ibeawuchi CM, Obajeun OA, Sarwar S, Tawfik C, Waleed MS, et al. Early Diagnosis of Autism Spectrum Disorder: A Review and Analysis of the Risks and Benefits. Cureus, (2023);15(8):1–14.

Bradshaw J, Steiner AM, Gengoux G, Koegel LK. Feasibility and Effectiveness of Very Early Intervention for Infants At-Risk for Autism Spectrum Disorder: A Systematic Review. Journal of autism and developmental disorders, (2015);45(3):778–94.

Emekli-Alturfan E, Alturfan AA. The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence. Molecular Biology Reports, (2023);50(1):815–28.

Brown TT, Jernigan TL. Brain development during the preschool years. Neuropsychology Review, (2012);22(4): 313–333.

Anderson V, Fenwick T, Manly T, Robertson I. Attentional skills following traumatic brain injury in childhood: A componential analysis, Brain Injury, (1998);12(11):937–49.

Barkley RA. The Executive Functions and Self-Regulation: An Evolutionary Neuropsychological Perspective. Neuropsychol Review, (2001);11(1):1–29.

Khalid W, Gill P, Arshad MS, Ali A, Ranjha MMAN, Mukhtar S, et al. Functional behavior of DHA and EPA in the formation of babies brain at different stages of age, and protect from different brain-related diseases. International Journal of Food Properties, (2022);25(1):1021–44.

Sun GY, Simonyi A, Fritsche KL, Chuang DY, Hannink M, Gu Z, et al. Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins, Leukotrienes and Essential Fatty Acids, (2018);136(September):3–13.

Brenna JT, Carlson SE. Docosahexaenoic acid and human brain development: Evidence that adietary supply is needed for optimal development. Journal of Human Evolution, (2014);77(December):99–106.

Gault CR, Obeid LM, Hannun YA. An overview of sphingolipid metabolism: From synthesis to breakdown. Advances in Experimental Medicine and Biology , (2010);688(April):1–23.

Babin F, Sarda P, Limasset B, Descomps B, Rieu D, Mendy F, et al. Nervonic acid in red blood cell sphingomyelin in premature infants: An index of myelin maturation? National Center for Biotechnology Information, (1993);28(7):627–30.

Smith SM, Nichols TE. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage, (2009);44(1):83–98.

Merrill AH, Sandhoff K. Chapter 14 Sphingolipids: metabolism and cell signaling. New Comprehensive Biochemistry, (2002);36(02):373–407.

Emekli-Alturfan E, Alturfan AA. The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence, Molecular Biology Reports, (2023);50(1):815–28.

Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science (80- ), (2010);327(5961):46–50.

Schneider N, Hauser J, Oliveira M, Cazaubon E, Mottaz SC, O’Neill B V., et al. Sphingomyelin in brain and cognitive development: Preliminary data. eNeuro, (2019);6(4):1–27.

Baker SK, Chen ZL, Norris EH, Revenko AS, MacLeod AR, Strickland S. Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer’s disease. Proceedings

of the National Academy of Sciences,(2018);115(41):E9687–96.

Schneider N, Hauser J, Oliveira M, Cazaubon E, Mottaz SC, O’Neill B V., et al. Sphingomyelin in brain and cognitive development: Preliminary data. eNeuro, (2019);6(4):1–27.

Ju J, Yang X, Jiang J, Wang D, Zhang Y, Zhao X, et al. Structural and Lipidomic Alterations of Striatal Myelin in 16p11.2 Deletion Mouse Model of Autism Spectrum Disorder. Frontiers in Cellular Neuroscience, (2021);15(August):1–25.

Dong MX, Li CM, Shen P, Hu QC, Wei YD, Ren YF, et al. Recombinant tissue plasminogen activator induces long-term anxiety-like behaviors via the ERK1/2-GAD1-GABA cascade in the hippocampus of a rat model. Neuropharmacology, (2018);128(5):119–31.

Bozkurt H, Şimşek Ş, Şahin S. Elevated levels of cortisol, brain-derived neurotropic factor and tissue plasminogen activator in male children with autism spectrum disorder. Autism Research, (2021);14(10):2078–84.

Yepes M, Roussel BD, Ali C, Vivien D. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.Trends in Neurosciences, (2009) ;32 (1) : 48–55.

Tsirka SE, Gualandris A, Amaral DG, Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature, (1995);377(6547):340–4.

Şimşek Ş, Çetin İ, Çim A, Kaya S. Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder. Autism Research, (2016);9(12):1241–7.

Wagner BA, Burns CP, Buettner GR. Free Radical-Mediated Lipid Peroxidation in Cells: Oxidizability Is a Function of Cell Lipid bis-Allylic Hydrogen Content. Biochemistry, (1994);33(15):4449–53.

Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. Journal of Leukocyte Biology, (2002);71(1):16–32.

Véricel E, Polette A, Bacot S, Calzada C, Lagarde M. Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets. Thrombosis and Haemostasis, (2003);1(3):566–72.

Cai J, Leung PS. Unlocking the potential of aquatic foods in global food security and nutrition: A missing piece under the lens of seafood liking index. Global Food Security, (2022);33(14):1–67.

Bragg MG, Prado EL, Stewart CP. Choline and docosahexaenoic acid during the first 1000 days and children’s health and development in low- and middle-income countries. Nutrition Reviews, (2022);80(4):656–76.

Song W, Zhang K, Xue T, Han J, Peng F, Ding C, et al. Cognitive improvement effect of nervonic acid and essential fatty acids on rats ingesting Acer truncatum Bunge seed oil revealed by lipidomics approach. Food & Function, (2022);13(5):2475–90.




DOI: http://dx.doi.org/10.62940/als.v11i1.2385

Refbacks

  • There are currently no refbacks.